stockrowHaemonetics Corporation
HAE Healthcare Medical Devices
Haemonetics Corporation’s revenue for fiscal 2026 (year ended March 2026) was $1.3 billion, down 1.97% from fiscal 2025.
- Revenue
- +9.30%
- EPS
- +25.6%
- Free cash flow
- +20.4%
- Total debt
- +22.1%
Quarter to September 2026, against a year earlier
Follow HAE
Alert me
Haemonetics Corporation (HAE) Free cash flow
Haemonetics Corporation's free cash flow for fiscal 2026 was $261.8M, up 58.0% from $165.7M in fiscal 2025. Over the twelve months to 30 September 2026 it was $300.0M. Over the past ten years it has ranged from $5.4M (fiscal 2015) to $261.8M (fiscal 2026) — the current reading is the highest in ten years. Free cash flow has risen for 5 consecutive fiscal years. Haemonetics Corporation ranks 15th of 149 Medical Devices companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2026 | $261.8M | 58.01% |
| FY2025 | $165.7M | 13.93% |
| FY2024 | $145.4M | 74.51% |
| FY2023 | $83.3M | 7.15% |
| FY2022 | $77.8M | 5.70% |
| FY2021 | $73.6M | (41.71%) |
| FY2020 | $126.2M | 192.66% |
| FY2019 | $43.1M | (70.92%) |
| FY2018 | $148.3M | 71.60% |
| FY2017 | $86.4M | 330.04% |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $113.9M | 155.08% |
| Jun 2026 | $44.7M | (17.01%) |
| Mar 2026 | $53.8M | (38.61%) |
| Dec 2025 | $87.6M | (17.64%) |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| BIO.B Bio-Rad Laboratories, Inc. compare | $468.1M |
| BIO Bio-Rad Laboratories, Inc. compare | $468.1M |
| HAE Haemonetics Corporation | $344.9M |
| BRKR Bruker Corporation compare | $244.7M |
| LIVN LivaNova PLC compare | $136.3M |
| TXG 10x Genomics compare | $121.4M |
| ITGR Integer Holdings Corporation compare | $81.8M |
| AXGN AxoGen, Inc. compare | $20.0M |
| IRTC iRhythm Holdings, Inc. compare | $7.4M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on HAE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement